ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,700.30
0.00%
S&P ASX All Technology
3,078.20
0.00%
Brent Oil
83.90
2.16%
US Dollar vs AUD
1.51195
-0.12%
Bitcoin
66,639.04
0.00%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Nuo Therapeutics Inc (QB) (AURX)

  7. Nuo Therapeutics Inc (QB) (AURX) News

AURX

Nuo Therapeutics (QB) (AURX)

Nuo Therapeutics Inc (QB)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:AURX
DateTimeSourceHeadlineSymbolCompany
12/06/202406:26Edgar (US Regulatory)Form 8-K - Current reportUSOTC:AURXNuo Therapeutics Inc (QB)
23/05/202402:40Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:AURXNuo Therapeutics Inc (QB)
22/05/202405:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:AURXNuo Therapeutics Inc (QB)
22/05/202405:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:AURXNuo Therapeutics Inc (QB)
21/05/202422:30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:AURXNuo Therapeutics Inc (QB)
16/05/202407:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:AURXNuo Therapeutics Inc (QB)
15/02/202405:58Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsUSOTC:AURXNuo Therapeutics Inc (QB)
13/02/202409:33Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]USOTC:AURXNuo Therapeutics Inc (QB)
23/12/202302:01Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:AURXNuo Therapeutics Inc (QB)
21/12/202306:18Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]USOTC:AURXNuo Therapeutics Inc (QB)
21/12/202306:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:AURXNuo Therapeutics Inc (QB)
21/12/202306:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:AURXNuo Therapeutics Inc (QB)
21/12/202301:02Edgar (US Regulatory)Form 8-K - Current reportUSOTC:AURXNuo Therapeutics Inc (QB)
21/11/202308:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:AURXNuo Therapeutics Inc (QB)
16/11/202301:37Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:AURXNuo Therapeutics Inc (QB)
09/08/202304:15Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:AURXNuo Therapeutics Inc (QB)
04/08/202306:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:AURXNuo Therapeutics Inc (QB)
04/08/202306:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:AURXNuo Therapeutics Inc (QB)
04/08/202306:15Edgar (US Regulatory)Form 8-K - Current reportUSOTC:AURXNuo Therapeutics Inc (QB)
16/05/202307:10Edgar (US Regulatory)Quarterly Report (10-q)USOTC:AURXNuo Therapeutics Inc (QB)
17/04/202320:08Edgar (US Regulatory)Annual Report (10-k)USOTC:AURXNuo Therapeutics Inc (QB)
15/11/202210:44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:AURXNuo Therapeutics Inc (QB)
05/11/202208:28Edgar (US Regulatory)Quarterly Report (10-q)USOTC:AURXNuo Therapeutics Inc (QB)
20/10/202223:36Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:AURXNuo Therapeutics Inc (QB)
20/10/202223:34Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:AURXNuo Therapeutics Inc (QB)
30/08/202222:16Edgar (US Regulatory)Current Report Filing (8-k)USOTC:AURXNuo Therapeutics Inc (QB)
11/08/202203:29Edgar (US Regulatory)Amended Quarterly Report (10-q/a)USOTC:AURXNuo Therapeutics Inc (QB)
09/08/202206:49Edgar (US Regulatory)Quarterly Report (10-q)USOTC:AURXNuo Therapeutics Inc (QB)
05/07/202222:03Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:AURXNuo Therapeutics Inc (QB)
05/07/202222:02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:AURXNuo Therapeutics Inc (QB)
 Showing the most relevant articles for your search:USOTC:AURX

Your Recent History

NASDAQ
QQQ
Invesco QQQ Trust Series 1
ASX
RIO
Rio Tinto
ASX
XJO
S&P ASX 200
FTSE
UKX
FTSE 100
ASX
QBE
QBE Insurance
ASX
FMG
Fortescue
NYSE
NKE
Nike
ASX
ANZ
Australia And New Zealan...
FX
GBPAUD
Sterling vs AUD
NASDAQ
TSLA
Tesla
ASX
XFL
S&P ASX 50
NASDAQ
MSFT
Microsoft
ASX
NAB
National Australia Bank
FX
AUDCAD
AUD vs CAD
FX
AUDUSD
AUD vs US Dollar
NYSE
MRK
Merck
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved